Results 171 to 180 of about 150,695 (362)

Assessment of peripheral nerve affection of the lower limbs in type 2 diabetic patients using neuromuscular ultrasound and electrodiagnostic studies

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Background Diabetic peripheral neuropathy is regarded as one of the most common microvascular sequalae of type 2 diabetes mellitus which leads to lower limb complications.
Mary Fayez Francis Hana   +3 more
doaj   +1 more source

GlyTwin: Digital Twin for Glucose Control in Type 1 Diabetes Through Optimal Behavioral Modifications Using Patient-Centric Counterfactuals [PDF]

open access: yesarXiv
Frequent and long-term exposure to hyperglycemia (i.e., high blood glucose) increases the risk of chronic complications such as neuropathy, nephropathy, and cardiovascular disease. Current technologies like continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) primarily model specific aspects of glycemic control-like ...
arxiv  

A narrative literature review about alpha‐lipoic acid role in dry eye and ocular surface disease

open access: yesActa Ophthalmologica, EarlyView.
Abstract Ocular surface diseases (OSD) include various conditions that affect the eye's surface, causing discomfort and pain. One such condition, dry eye disease (DED), is a multifactorial disorder that significantly impacts patients' quality of life, with prevalence rates ranging from 5% to 50% and higher incidence in women.
Antonio J. Mateo Orobia   +4 more
wiley   +1 more source

Sympathetic mediated vasomotion and skin capillary permeability in diabetic patients with peripheral neuropathy [PDF]

open access: bronze, 2003
J. D. Lefrandt   +6 more
openalex   +1 more source

Pharmacokinetics and pharmacodynamics of intranasal insulin in a rat brain

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Understanding of the insulin‐mediated effects on signalling and metabolism is important not only for fundamental knowledge of insulin's action in the brain but also for elucidating the mechanism of therapeutic potential in neurodegenerative disorders with underlying brain metabolic dysfunction.
Jelena Osmanovic Barilar   +7 more
wiley   +1 more source

Diagnostic testing and treatment in Japanese patients with a diagnosis code for chronic inflammatory demyelinating polyradiculoneuropathy: A claims database analysis

open access: yesClinical and Experimental Neuroimmunology, Volume 16, Issue 2, Page 98-107, May 2025.
Abstract Objectives Reports of real‐world data concerning chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are limited in Japan. This study aimed to investigate the diagnostic testing and treatment performed in patients diagnosed with CIDP in Japan. Methods Using a Japanese commercial medical information database, we analyzed diagnostic
Motoi Kuwahara   +5 more
wiley   +1 more source

Validation of a Modified Version of the Brief Pain Inventory for Painful Diabetic Peripheral Neuropathy [PDF]

open access: bronze, 2005
Diane C. Zelman   +4 more
openalex   +1 more source

Real‐world safety and treatment patterns of subcutaneous IgPro20 for chronic inflammatory demyelinating polyneuropathy: Post‐marketing surveillance in Japan

open access: yesClinical and Experimental Neuroimmunology, Volume 16, Issue 2, Page 108-117, May 2025.
Abstract Objectives IgPro20, a subcutaneous immunoglobulin replacement therapy, is approved in Japan for chronic inflammatory demyelinating polyneuropathy (CIDP). This post‐marketing surveillance study characterized real‐world treatment patterns and safety profile of injection site reactions associated with IgPro20 treatment in Japanese patients with ...
Naoki Terasaka   +4 more
wiley   +1 more source

Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers, third edition

open access: yes
The Journal of Dermatology, EarlyView.
Yoshihide Asano   +27 more
wiley   +1 more source

Home - About - Disclaimer - Privacy